Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2008.02852.x/fullpdf
Reference12 articles.
1. Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A;Goudemand;Blood,2006
2. Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development;Escuriola-Ettingshausen;Haemophilia,2006
3. Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A;Chalmers;Haemophilia,2007
4. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study;Gouw;Blood,2007
5. Associations between type of product and inhibitors in previously untreated patients (PUPs) with severe hemophilia: switches and particular products can disturb analysis;Calvez;Blood,2007
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of the Survey of Inhibitors in Plasma‐Product Exposed Toddlers (SIPPET) study and its post hoc analyses on clinical practice in the United States: A survey of Haemophilia and Thrombosis Research Society members;Haemophilia;2019-07-02
2. Over two decades of orthopaedic surgery in patients with inhibitors-Quantifying the complication of bleeding;Haemophilia;2018-12-03
3. Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors;Cellular Immunology;2018-09
4. A close insight to factor VIII inhibitor in the congenital hemophilia A;Expert Review of Hematology;2016-08-16
5. Key insights to understand the immunogenicity of FVIII products;Thrombosis and Haemostasis;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3